If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
263.00    -15.00 (-5.40%)
Bid:
274.00
Ask:
277.00
Spread: 3.00 (1.095%)
Market Cap: £235.53m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Director/PDMR Shareholding

22 Dec 2010 14:16

RNS Number : 4620Y
Wilmington Group Plc
22 December 2010
 



 

 

Wilmington Group plc

Directors and PDMR's Share Transactions

 

In accordance with DTR 3.1.2, Wilmington Group plc announces that in accordance with the terms and performance criteria of the Wilmington Group plc 2007 Performance Plan, a portion of the awards made to the Company's Directors and Persons Discharging Managerial Responsibility ('PDMRs') on 5 December 2007, which were made at nil value, vested on 5 December 2010. A total of 76,302 ordinary shares of 5p each in the Company ("Ordinary Shares") have vested as follows:

 

Name of Director/PDMR Number of Ordinary Shares vesting under the Award

 

Charles Brady (Chief Executive) 29,651

Basil Brookes (Finance Director) 20,162

Rory Conwell (former Director) 9,884

Neil Smith (PDMR) 8,777

Stephen Broome (PDMR) 7,828

 

As a result of this transaction Charles Brady now holds 3,412,151 Ordinary Shares, which represents 4.12% of the issued share capital with voting rights ("Share Capital").

 

On 22 December 2010, Basil Brookes sold 10,283 of these vesting shares at 159p, in order to settle the tax liabilities arising. His resultant holding of Ordinary Shares is now 855,541, which represents 1.03% of the Share Capital.

 

Rory Conwell's holding of Ordinary Shares is now 3,890,669 which represents 4.69% of the Share Capital.

 

On 22 December 2010 both Neil Smith and Stephen Broome sold their vesting shares at 159p, and their holdings of Ordinary Shares remain at 276,309 and 233,000 respectively. This represents 0.33% and 0.28% respectively of the Share Capital.

 

For further information please contact:

 

Richard Cockton, Company Secretary

Wilmington Group plc 0207 422 6803

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBSBDDLBDBGGD
Date   Source Headline
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20254:39 pmRNSDirector/PDMR Shareholding
3rd Mar 20254:35 pmRNSDirector/PDMR Shareholding
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSShare repurchase programme
17th Feb 20257:00 amRNSHalf-year Report
17th Jan 20259:42 amRNSNotice of Half Year Results
4th Dec 20247:00 amRNSDirector/PDMR Shareholding
28th Nov 202411:03 amRNSResult of AGM
25th Nov 20241:37 pmRNSHolding(s) in Company
20th Nov 20247:00 amRNSDirector/PDMR Shareholding
8th Nov 20243:13 pmRNSDirector/PDMR Shareholding
1st Nov 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSAcquisition of Phoenix Health & Safety
21st Oct 20241:47 pmRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSIssue of Ordinary Shares
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSFinancial results for the year ended 30 June 2024
2nd Sep 20247:00 amRNSTotal Voting Rights
29th Jul 20248:59 amRNSDirector Declaration
24th Jul 20247:00 amRNSTrading Statement
10th Jul 202410:57 amRNSHolding(s) in Company
2nd Jul 20242:51 pmRNSTotal Voting Rights - Replacement
1st Jul 20247:00 amRNSTotal Voting Rights
27th Jun 20247:00 amRNSUK Healthcare Business sold for £26.3 million
26th Apr 20247:46 amRNSAPM sold for EUR 26 million
23rd Apr 20243:49 pmRNSSAYE and Director/PDMR Shareholding
19th Feb 20247:00 amRNSHalf-year Report
6th Feb 202411:12 amRNSBoard Changes
1st Feb 20247:00 amRNSMiExact sold for £9.6 million
18th Jan 202411:00 amRNSNotice of Half Year Results
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20232:42 pmRNSIssue of ordinary shares
11th Dec 20233:54 pmRNSIssue of Ordinary Shares
7th Dec 20232:25 pmRNSIssue of Ordinary Shares
1st Dec 202311:40 amRNSDirector/PDMR Shareholding
30th Nov 20232:53 pmRNSIssue of Ordinary Shares
23rd Nov 20239:49 amRNSAcquisition of Astutis Ltd by Wilmington plc
22nd Nov 20232:37 pmRNSResult of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
3rd Oct 20232:52 pmRNSHolding(s) in Company
2nd Oct 202311:57 amRNSDirector/PDMR Shareholding
2nd Oct 202310:19 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSIssue of Ordinary Shares
25th Sep 20236:06 pmRNSAmendment to Financial Results announcement
25th Sep 20237:00 amRNSFinancial results for the year ended 30 June 2023
26th Jul 20237:00 amRNSTrading Statement
11th Apr 20237:00 amRNSSAYE and Director/PDMR Shareholding
7th Mar 20235:32 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.